Welcome to our online store!

More Views

Pramistar 20 tablest 600mg Pramiracetam Прамистар BERLIN CHEMIE Concentration & Attention disorders

Product sku: MD1786

Availability: In stock

Only 66 left


Quick Overview

Brain activity disorders



Pramistar Indications

Decreased ability to concentrate; memory impairment degenerative or vascular origin, particularly in the elderly.


Hypersensitivity to the active substance or other components of the drug, bleeding in the brain, severe kidney failure, liver failure, pregnancy and lactation.

Dosage & Administration

Oral administration, of 1 tablet 2 times a day. Clinically significant effect can be expected no earlier than 4-8 weeks of treatment.

Elderly patients. Dose adjustment is not needed.

Patients with renal failure. In renal insufficiency excretion pramiratsetama point decline, the clinical significance of which is not defined, therefore use in patients with renal insufficiency should be under the control of kidney function and the development of side effects cancel it, as this may be signs of accumulation of the active substance in the body.


Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.